Stock Plans and Management Compensation (Details 1) (USD $)
|
12 Months Ended | |||||
---|---|---|---|---|---|---|
Dec. 31, 2014
|
Dec. 31, 2013
|
Dec. 31, 2012
|
||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Authorized number of shares (in shares) | 5,000,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | |||||
Number of shares available for grant (in shares) | 5,400,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | |||||
SARs/Stock Options Outstanding [Roll Forward] | ||||||
Outstanding on December 31 | 2,700,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | 3,800,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | 8,200,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | |||
Exercisable on December 31 | 2,300,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | 2,600,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | 5,500,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | |||
Stock Options and SARs [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Period for stock options and SARs to be exercisable (in years) | 10 years | |||||
Awards vesting period (in years) | 4 years | |||||
SARs/Stock Options Outstanding [Roll Forward] | ||||||
Outstanding on January 1 |
3,825,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
8,166,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
9,347,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Granted |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
0us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
400,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Exercised |
(1,084,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
(4,156,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
(1,120,000)us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Forfeited |
(36,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
(185,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
(461,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Outstanding on December 31 |
2,705,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
3,825,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
8,166,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Exercisable on December 31 |
2,294,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
2,607,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
5,489,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Weighted Average Exercise Price [Abstract] | ||||||
Outstanding on January 1 |
$ 19.09us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 17.33us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 16.66us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Granted |
$ 0.00us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 0.00us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 23.80us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Exercised |
$ 24.02us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 14.80us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 11.05us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Forfeited |
$ 35.10us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 37.38us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 25.69us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Outstanding on December 31 |
$ 16.91us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 19.09us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 17.33us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Exercisable on December 31 |
$ 16.03us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 19.73us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
$ 18.89us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Weighted Average Remaining Contractual Term [Abstract] | ||||||
Outstanding on December 31 | 4 years 9 months 18 days | |||||
Exercisable on December 31 | 4 years 7 months 6 days | |||||
Aggregate Intrinsic Value [Abstract] | ||||||
Exercised |
$ 23,611,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||||
Outstanding on December 31 |
92,908,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||||
Exercisable on December 31 |
80,809,000us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||||
Risk-free interest rate |
1.10%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||||
Dividend yield |
0.20%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||||
Volatility factor (A) |
58.30%us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
[1] | ||||
Share-based compensation expense |
1,300,000us-gaap_AllocatedShareBasedCompensationExpense / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
3,000,000us-gaap_AllocatedShareBasedCompensationExpense / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
6,400,000us-gaap_AllocatedShareBasedCompensationExpense / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_StockOptionsAndSarsMember |
|||
Stock Options and SARs [Member] | Minimum [Member] | ||||||
Aggregate Intrinsic Value [Abstract] | ||||||
Weighted average expected life, minimum (in years) | 5 years 2 months 12 days | |||||
Stock Options and SARs [Member] | Maximum [Member] | ||||||
Aggregate Intrinsic Value [Abstract] | ||||||
Weighted average expected life, minimum (in years) | 6 years 8 months 12 days | |||||
Stock Options and SARs Awarded Prior to 2006 [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Age of grantee plus grantees total number of years of service | 65 | |||||
SARs Granted in 2006 through April 2009 [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Age of grantee plus grantees total number of years of service | 70 | |||||
Aggregate Intrinsic Value [Abstract] | ||||||
Age of grantee | 62 years | |||||
SARs modified on May 2009 and thereafter [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Age of grantee plus grantees total number of years of service | 70 | |||||
Aggregate Intrinsic Value [Abstract] | ||||||
Age of grantee | 62 years | |||||
Stock Appreciation Rights (SARs) [Member] | ||||||
Aggregate Intrinsic Value [Abstract] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award, SARs, Grants in Period, Weighted Average Grant Date Fair Value |
$ 12.70us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = us-gaap_StockAppreciationRightsSARSMember |
|||||
Non-Vested Stock Awards [Member] | ||||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||||
Age of grantee plus grantees total number of years of service | 70 | |||||
Aggregate Intrinsic Value [Abstract] | ||||||
Age of grantee | 62 years | |||||
Share-based compensation expense |
10,500,000us-gaap_AllocatedShareBasedCompensationExpense / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
10,100,000us-gaap_AllocatedShareBasedCompensationExpense / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
6,400,000us-gaap_AllocatedShareBasedCompensationExpense / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward] | ||||||
Outstanding at January 1 |
815,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
798,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
541,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Granted |
322,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
298,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
306,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Released |
(220,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
(266,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
(20,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Forfeited |
(37,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
(15,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
(29,000)us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Outstanding at December 31 |
880,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
815,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
798,000us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Unrecognized compensation cost |
$ 5,700,000us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||||
Weighted average price at grant date (in dollars per share) |
$ 40.41us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
$ 34.64us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
$ 23.79us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue / bc_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTypeAxis = bc_NonVestedStockAwardsMember |
|||
Unrecognized compensation cost, period for recognition | 9 months 18 days | |||||
Awards vesting period, other than options, lower range | 3 years | |||||
Awards vesting period, other than options, upper range | 4 years | |||||
|
X | ||||||||||
- Definition
Grantee continues to vest in SARs in accordance with vesting schedule even upon termination if the employee has reached this age No definition available.
|
X | ||||||||||
- Definition
Vesting in accordance with the applicable vesting schedule even upon termination of employment by adding the age of grantee and grantee's total number of years of service. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Description of the period of time, at lower range, over which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition. No definition available.
|
X | ||||||||||
- Definition
Description of the period of time, at upper range, over which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Unrecognized cost of unvested share-based compensation awards. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The risk-free interest rate assumption that is used in valuing an option on its own shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Net number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Definition
Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Definition
Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
X | ||||||||||
- Definition
Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. No definition available.
|
X | ||||||||||
- Definition
Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. No definition available.
|
X | ||||||||||
- Definition
Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|